top of page
Search
Writer's pictureAndrew Bruice

Global Assisted Reproductive Technology (ART) Market Industry Statistics

Report Details-


Global Assisted Reproductive Technology (ART) Market By Procedure (Fresh Donor, Fresh Nondonor, Frozen Donor, Frozen Nondonor, Embryo/Egg Banking), Technology (In-vitro Fertilization (IVF), Artificial Insemination - Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER), Others), Product Type (Women Younger Than Age 35, Women Older Than Age 35), End Use (Hospitals, Fertility Clinics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Rest of Middle East & Africa), Market Trends and Forecast to 2027


Market Analysis and Insights of Global Assisted Reproductive Technology (ART) Market

Assisted reproductive technology (ART) market is expected to reach market value of USD 45.54 billion by 2027 growing with the CAGR of 8.05% in the forecast period of 2020-2027. The increasing cases of infertility due to obesity, rising stress and pollution has been directly impacting the growth of assisted reproductive technology (ART) market.

Rising awareness and social acceptance of assisted reproductive technologies and increasing cases of infertility rate along with surging number of single women and preferences of same sex couples are some of the factors that will drive the growth of the assisted reproductive technology (ART) market in the forecast period of 2020-2027. Another impactful reason that will increase the demand is change in sedentary lifestyle and increasing consumption of unhealthy food will uplift the market growth.

Increasing cost of medical procedures along with raising ethical issues, prematurity risk associated with assisted reproductive technologies and less success rate will hamper the growth of the assisted reproductive technologies (ART) market in the forecast period of 2020-2027.


Global Assisted Reproductive Technologies (ART) Market Scope and Market Size

Assisted reproductive technology (ART) market is segmented on the basis of procedure, technology, product type and end-use. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on procedure, the assisted reproductive technology (ART) market is segmented into fresh donor, fresh nondonor, frozen donor, frozen nondonor, embryo/egg banking.

  • Assisted reproductive technology (ART) market has also been segmented on the basis of technology into in-vitro fertilization (IVF), artificial insemination - intrauterine insemination (AI-IUI), frozen embryo replacement (FER) and others. In-vitro fertilization (IVF) has been further segmented into IVF with intracytoplasmic sperm injection (ICSI), IVF without ICSI.

  • Based on product type, the assisted reproductive technology (ART) market is segmented into women younger than age 35 and women older than age 35

  • Assisted reproductive technology (ART) market has also been segmented on the basis of end-use into hospitals, fertility clinics and others



Assisted Reproductive Technology (ART) Market Country Level Analysis

Assisted reproductive technology (ART) market is analysed and market size insights and trends are provided by country, procedure, technology, product type and end use as referenced above.


The countries covered in the assisted reproductive technology (ART) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.


Europe dominates the assisted reproductive technology (ART) market due to rising infertility rate and increasing awareness regarding fertility treatment, while Asia-Pacific is expected to grow with the highest growth rate in the forecast period of 2020 to 2027 because of the adoption of late family planning and lower treatment cost


Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Assisted reproductive technology (ART) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for assisted reproductive technology (ART) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the assisted reproductive technology (ART) market. The data is available for historic period 2010 to 2018.



Competitive Landscape and Assisted Reproductive Technology (ART) Market Share Analysis

Assisted reproductive technology (ART) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to assisted reproductive technology (ART) market.

The major players covered in the assisted reproductive technology (ART) market report are California Cryobank, Bloom Fertility Centre, Parallabs Ltd, Anecova, A CooperSurgical Fertility Company, Merck KGaA, Ferring B.V., FUJIFILM Irvine Scientific, Cook, Genea Limited., IVFtech ApS, Nidacon International AB, Celmatix Inc., EMD Serono, Inc., Esco Micro Pte Ltd., INVO Bioscience, Laboratoire CCD, Nikon Instruments Inc., Smiths Medical, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.




Major TOC of the Report

· INTRODUCTION

· MARKET SEGMENTATION

· MARKET OVERVIEW

· EXECUTIVE SUMMARY



About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818


Browse Related Reports@






#Global Assisted Reproductive Technology (ART) Market, #Healthcare,

2 views0 comments

Recent Posts

See All

Comentários


Post: Blog2_Post
bottom of page